Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients. [electronic resource]
Producer: 20171002Description: 411-419 p. digitalISSN:- 1433-8726
- Adaptor Proteins, Signal Transducing -- metabolism
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Cell Cycle Proteins
- Class Ia Phosphatidylinositol 3-Kinase
- Class Ib Phosphatidylinositol 3-Kinase -- metabolism
- Female
- Humans
- Immunohistochemistry
- Indoles -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- PTEN Phosphohydrolase -- metabolism
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoproteins -- metabolism
- Prognosis
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyrroles -- therapeutic use
- Retrospective Studies
- Ribosomal Protein S6 Kinases, 70-kDa -- metabolism
- Sunitinib
- Survival Rate
- TOR Serine-Threonine Kinases -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.